Tychon Bioscience - About the company
Tychon Bioscience is a seed company based in Minneapolis (United States), founded in 2011 by Troy Kopischke and Danny Cunagin. It operates as a Novel oncolytic immunotherapy transforming immune cells to fight cancer. Tychon Bioscience has raised $671K in funding. The company has 3416 active competitors, including 1151 funded and 805 that have exited. Its top competitors include companies like Jazz Pharmaceuticals, BeiGene and Sana Biotechnology.
Company Details
Novel oncolytic immunotherapy transforming immune cells to fight cancer. The company is advancing precision cancer immunotherapy through a novel approach. This approach transforms a patient’s immune cells into a “PAR-T” cell trained to find and eliminate cancer cells. The therapy addresses shortcomings of existing T-cell based immunotherapies. The PAR-T technology can be used as a primary therapy or in combination with other therapies, opening up enormous untapped potential to treat early and late-stage cancers. The company is introducing a protein-based drug that activates T-cells to find and eliminate cancer. The therapy aims for safer, faster, cheaper, patient-friendly, and controllable treatment. This innovative approach in cancer treatment represents a significant advancement in the field of immunotherapy.
- Website
- www.tychonbio.com/
- Email ID
- *****@tychonbio.com
- Phone Number
- +1 **********
Key Metrics
Founded Year
2011
Location
Minneapolis, United States
Stage
Seed
Total Funding
$671K in 2 rounds
Latest Funding Round
Ranked
2039th among 3416 active competitors
Employee Count
1 - 10 as on Jul 01, 2024
Similar Companies
Legal entities associated with Tychon Bioscience
Tychon Bioscience is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
Tychon Biosciences LLC CIN: 464674295 , United States, Active | - | - | - |
Sign up to download Tychon Bioscience's company profile
Tychon Bioscience's funding and investors
Tychon Bioscience has raised a total funding of $671K over 2 rounds. Its first funding round was on Nov 24, 2015.
Here is the list of recent funding rounds of Tychon Bioscience:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Oct 09, 2018 | 3982570 | Seed | 9662160 | 6790332 | 8691577 | 4390937 |
Nov 24, 2015 | 8204371 | Seed | 5369696 | 3867470 | 4125790 | 8050704 |
Access funding benchmarks and valuations. Sign up today!View details of Tychon Bioscience's funding rounds and investors
Tychon Bioscience's founders and board of directors
Founder? Claim ProfileThe founders of Tychon Bioscience are Troy Kopischke and Danny Cunagin.
Here are the details of Tychon Bioscience's key team members:
- Troy Kopischke: Co-Founder & Co-CEO of Tychon Bioscience and founder of 2 other companies, Flywheel and OneOme.
- Danny Cunagin: Co-Founder & Co-CEO of Tychon Bioscience. Contact Info: 1 email address
View details of Tychon Bioscience's Founder profiles and Board Members
Tychon Bioscience's employee count trend
Tychon Bioscience has 1 - 10 employees as of Jul 24. Here is Tychon Bioscience's employee count trend over the years:
Uncover Tychon Bioscience's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Tychon Bioscience's Competitors and alternates
Top competitors of Tychon Bioscience include Jazz Pharmaceuticals, BeiGene and Sana Biotechnology. Here is the list of Top 10 competitors of Tychon Bioscience, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st |  Jazz Pharmaceuticals 2003, Dublin (Ireland), Public | Developer of novel biopharmaceutical medicines for unmet medical needs | $265M | 81/100 | |
2nd |  BeiGene 2010, Cambridge (United States), Public | Developer of targeted and immune-oncology drugs against cancer | $172M | 81/100 | |
3rd |  Sana Biotechnology 2018, Seattle (United States), Public | Developer of engineered cell therapies for treating various human diseases | $821M | 74/100 | |
4th | Ideaya Biosciences 2015, San Francisco (United States), Public | Developer of oncology-focused precision medicine using molecular diagnostics | $157M | 73/100 | |
5th | Senti Bio 2016, San Francisco (United States), Public | Developer of cell and gene therapies for patients living with incurable diseases | $158M | 72/100 | |
6th | Sutro Biopharma 2003, United States, Public | Developer of antibody-based therapeutics for cancer therapy | $175M | 72/100 | |
7th | Syndax 2005, Waltham (United States), Public | Developer of targeted therapies for the treatment of cancer | $198M | 72/100 | |
8th | Developer of T-cell therapies for the treatment of cancer | $49.8M | 72/100 | ||
9th |  Moderna 2010, Cambridge (United States), Public | Developer of mRNA-based therapeutics for a wide range of diseases | $2.78B | 72/100 | |
10th | C4 Therapeutics 2016, Cambridge (United States), Public | Developer of small molecule drugs for treating cancer | $223M | 71/100 | |
2039th | Tychon Bioscience 2011, Minneapolis (United States), Seed | Novel oncolytic immunotherapy transforming immune cells to fight cancer | $671K | - | 28/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Tychon Bioscience's competitors? Click here to see the top ones
Tychon Bioscience's Investments and acquisitions
Tychon Bioscience has made no investments or acquisitions yet.
Reports related to Tychon Bioscience
Here is the latest report on Tychon Bioscience's sector:
Are you a Founder ?
FAQs about Tychon Bioscience
Explore our recently published companies
- Complementos de Piensos Compuestos - Navarres based, 1978 founded, Acquired company
- Albright & Wilson (Australia) - 1939 founded, Unfunded company
- Davcsp - India based, Unfunded company
- Inergy Fitness - Bulgaria based, Unfunded company
- VSG Direkt - Austria based, 1989 founded, Unfunded company
- PKI Electronic Intelligence - Lutjensee based, Unfunded company
